Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction

被引:41
作者
Waters, RE
Singh, KP
Roe, MT
Lotfi, M
Sketch, MH
Mahaffey, KW
Newby, LK
Alexander, JH
Harrington, RA
Califf, RM
Granger, CB
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Duke Clin Res Inst, Durham, NC USA
关键词
D O I
10.1016/j.jacc.2003.12.057
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The focus for the initial approach to the treatment of acute ST-segment elevation myocardial infarction (STEMI) has shifted toward extending the benefits of mechanical reperfusion with primary percutaneous coronary intervention (PCI) to patients who present to community hospitals that have no interventional capabilities. Several randomized clinical trials have shown that transferring STEMI patients to tertiary centers for primary PCI leads to better outcomes than when fibrinolytic therapy is administered at community hospitals. Furthermore, potent pharmacologic reperfusion regimens that enhance early reperfusion of the infarct vessel before primary PCI may enhance the positive result of the transfer approach. Despite these promising findings, several obstacles have hindered the adoption of patient-transfer strategies in the U.S., including greater distances between community and tertiary hospitals, a lack of integrated emergency medical services, and the medical community's limited experience with centralized acute myocardial infarction (AMI) care networks. Nonetheless, the implementation of system-wide changes in the care of STEMI patients analogous to the creation of trauma networks could facilitate the creation and ongoing evaluation of dedicated patient transfer strategies and better early invasive care in the U.S. Within this context, a systematic, stepwise approach to the creation of AMI care networks and to the development of standard nomenclature and performance indicators is necessary to guide quality assurance monitoring and future research efforts as the care of STEMI patients is redefined. Consequently, this current evolution of reperfusion strategies has the potential to further reduce morbidity and mortality for patients presenting with STEMI. (C) 2004 by the American College of Cardiology Foundation(.)
引用
收藏
页码:2153 / 2159
页数:7
相关论文
共 30 条
[1]   A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction [J].
Andersen, HR ;
Nielsen, TT ;
Rasmussen, K ;
Thuesen, L ;
Kelbaek, H ;
Thayssen, P ;
Abildgaard, U ;
Pedersen, F ;
Madsen, JK ;
Grande, P ;
Villadsen, AB ;
Krusell, LR ;
Haghfelt, T ;
Lomholt, P ;
Husted, SE ;
Vigholt, E ;
Kjaergard, HK ;
Mortensen, LS .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (08) :733-742
[2]   Abciximab facilitates the rate and extent of thrombolysis - Results of the thrombolysis in myocardial infarction (TIMI) 14 trial [J].
Antman, EM ;
Giugliano, RP ;
Gibson, CM ;
McCabe, CH ;
Coussement, P ;
Kleiman, NS ;
Vahanian, A ;
Adgey, AAJ ;
Menown, I ;
Rupprecht, HJ ;
Van der Wieken, R ;
Ducas, J ;
Scherer, J ;
Anderson, K ;
Van de Werf, F ;
Braunwald, E .
CIRCULATION, 1999, 99 (21) :2720-2732
[3]   INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS [J].
APPLEBY, P ;
BAIGENT, C ;
COLLINS, R ;
FLATHER, M ;
PARISH, S ;
PETO, R ;
BELL, P ;
HALLS, H ;
MEAD, G ;
DIAZ, R ;
PAOLASSO, E ;
PAVIOTTI, C ;
ROMERO, G ;
CAMPBELL, T ;
OROURKE, MF ;
THOMPSON, P ;
LESAFFRE, E ;
VANDEWERF, F ;
VERSTRAETE, M ;
ARMSTRONG, PW ;
CAIRNS, JA ;
MORAN, C ;
TURPIE, AG ;
YUSUF, S ;
GRANDE, P ;
HEIKKILA, J ;
KALA, R ;
BASSAND, JP ;
BOISSEL, JP ;
BROCHIER, M ;
LEIZOROVICZ, A ;
BRUGGEMANN, T ;
KARSCH, KR ;
KASPER, W ;
LAMMERTS, D ;
NEUHAUS, KL ;
MEYER, J ;
SCHRODER, R ;
VONESSEN, R ;
SARAN, RK ;
ARDISSINO, D ;
BONADUCE, D ;
BRUNELLI, C ;
CERNIGLIARO, C ;
FORESTI, A ;
FRANZOSI, MG ;
GUIDUCCI, D ;
MAGGIONI, A ;
MAGNANI, B ;
MATTIOLI, G .
LANCET, 1994, 343 (8893) :311-322
[4]   Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery - A randomized controlled trial [J].
Aversano, T ;
Aversano, LT ;
Passamani, E ;
Knatterud, GL ;
Terrin, ML ;
Williams, DO ;
Forman, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (15) :1943-1951
[5]   Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction [J].
Cannon, CP ;
Gibson, CM ;
Lambrew, CT ;
Shoultz, DA ;
Levy, D ;
French, WJ ;
Gore, JM ;
Weaver, WD ;
Rogers, WJ ;
Tiefenbrunn, AJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (22) :2941-+
[6]   The volume of primary angioplasty procedures and survival after acute myocardial infarction [J].
Canto, JG ;
Every, NR ;
Magid, DJ ;
Rogers, WJ ;
Malmgren, JA ;
Frederick, PD ;
French, WJ ;
Tiefenbrunn, AJ ;
Misra, VK ;
Kiefe, CI ;
Barron, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (21) :1573-1580
[7]   Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction - A meta-analysis [J].
Dalby, M ;
Bouzamondo, A ;
Lechat, P ;
Montalescot, G .
CIRCULATION, 2003, 108 (15) :1809-1814
[8]   Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction - Results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) phase II angiographic trial [J].
Giugliano, RP ;
Roe, MT ;
Harrington, RA ;
Gibson, M ;
Zeymer, U ;
Van de Werf, F ;
Baran, KW ;
Hobbach, HP ;
Woodlief, LH ;
Hannan, KL ;
Greenberg, S ;
Miller, J ;
Kitt, MM ;
Strony, J ;
McCabe, CH ;
Braunwald, E ;
Califf, RM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (08) :1251-1260
[9]   Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction:: Six-month follow up and analysis of individual patient data from randomized trials [J].
Grines, C ;
Patel, A ;
Zijlstra, F ;
Weaver, WD ;
Granger, C ;
Simes, RJ ;
Ellis, S ;
Betriu, A ;
Grines, C ;
Garcia, E ;
Grinfeld, L ;
Gibbons, R ;
Ribeiro, E ;
Ribichini, F ;
Akhras, F ;
Jones, M ;
Topol, E ;
Califf, R ;
Van der Werf, F ;
Ardissino, D ;
Armstrong, PW ;
Aylward, P ;
Bates, E ;
Beatt, K ;
Cheseboro, J ;
Col, J ;
Emanuelsson, H ;
Fuster, V ;
Gibler, WB ;
Gore, J ;
Guerci, A ;
Hochman, J ;
Holmes, D ;
Kleiman, N ;
Morris, D ;
Neuhaus, K ;
Ohman, M ;
Pfisterer, M ;
Phillips, H ;
Rutsch, W ;
Simoons, M ;
Vahanian, A ;
White, H ;
Stone, G ;
Browne, K ;
Marco, J ;
Rothbaum, D ;
O'Keefe, DRJ ;
Overlie, P ;
Donohue, B .
AMERICAN HEART JOURNAL, 2003, 145 (01) :47-57
[10]   A Randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction - The Air Primary Angioplasty in Myocardial Infarction study [J].
Grines, CL ;
Westerhausen, DR ;
Grines, LL ;
Hanlon, JT ;
Logemann, TL ;
Niemela, M ;
Weaver, WD ;
Graham, M ;
Boura, J ;
O'Neill, WW ;
Balestrini, C .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (11) :1713-1719